Diametric Capital, LP Regeneron Pharmaceuticals, Inc. Transaction History

Diametric Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $956,768 - $1.41 Million	-2,846 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $780,173 - $1.07 Million	2,846 New	2,846 $1.07 Million
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $1.22 Million - $1.42 Million	-4,463 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $1.06 Million - $1.47 Million	3,540 Added 383.53%	4,463 $1.4 Million
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $998,662 - $1.18 Million	-2,684 Reduced 74.41%	923 $374,000
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $1.21 Million - $1.45 Million	3,607 New	3,607 $1.35 Million

1,531

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Diametric Capital, LP with notifications on news.